The U.S. Food and Drug Administration is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence (OCE). Project Orbis provides a framework for concurrent submission and review of oncology drugs among its international partners. Under this project, the FDA, the Australian Therapeutic Goods Administration (TGA) and Health Canada collaboratively reviewed applications for two oncology drugs, allowing for simultaneous decisions in all three countries.
About time this happened . Could be a handy innovation when the time comes for Efti combo
Media, page-243
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.015(4.23%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.8¢ | 33.5¢ | $1.374M | 3.957M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 95461 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 48512 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |